Souders Financial Advisors’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$288K Buy
10,269
+151
+1% +$4.02K 0.03% 188
2025
Q4
$252K Buy
10,118
+1,423
+16% +$35.9K 0.03% 194
2025
Q3
$222K Buy
+8,695
New +$215K 0.03% 192
2025
Q2
Sell
-9,292
Closed -$235K 207
2025
Q1
$235K Buy
9,292
+964
+12% +$25.2K 0.03% 170
2024
Q4
$221K Buy
8,328
+127
+2% +$3.44K 0.03% 170
2024
Q3
$237K Sell
8,201
-146
-2% -$4.26K 0.03% 160
2024
Q2
$234K Buy
8,347
+483
+6% +$13.3K 0.04% 153
2024
Q1
$218K Sell
7,864
-3,376
-30% -$93.7K 0.03% 154
2023
Q4
$324K Buy
11,240
+777
+7% +$23.5K 0.06% 141
2023
Q3
$347K Sell
10,463
-60,540
-85% -$2.14M 0.07% 133
2023
Q2
$2.6M Sell
71,003
-3,143
-4% -$122K 0.5% 62
2023
Q1
$3.03M Buy
74,146
+2,714
+4% +$117K 0.64% 52
2022
Q4
$3.66M Buy
71,432
+2,709
+4% +$130K 0.84% 34
2022
Q3
$3.01M Sell
68,723
-8,959
-12% -$435K 0.82% 37
2022
Q2
$4.07M Buy
77,682
+2,072
+3% +$106K 1.17% 23
2022
Q1
$3.91M Buy
75,610
+348
+0.5% +$18.1K 1.13% 23
2021
Q4
$4.44M Buy
75,262
+731
+1% +$36.2K 1.28% 18
2021
Q3
$3.21M Buy
74,531
+1,051
+1% +$46.6K 1.03% 28
2021
Q2
$2.88M Buy
73,480
+1,129
+2% +$43.9K 0.97% 34
2021
Q1
$2.62M Buy
72,351
+23,529
+48% +$835K 1.03% 32
2020
Q4
$1.8M Sell
48,822
-2,165
-4% -$79.4K 0.78% 42
2020
Q3
$1.87M Buy
50,987
+2,277
+5% +$79.8K 0.88% 40
2020
Q2
$1.51M Buy
48,710
+20,968
+76% +$712K 0.86% 40
2020
Q1
$859K Buy
+27,742
New +$945K 0.76% 36

Other funds holding PFE

Souders Financial Advisors's PFE Position: Q1 2026 in Review

Souders Financial Advisors increased its Pfizer (PFE) stake by 1.5% in Q1 2026, buying an estimated $4.02K and bringing the position to 10,269 shares worth $288K. The position accounts for 0.03% of the portfolio, ranked #188.

Souders Financial Advisors first reported a position in PFE in Q1 2020 and has held it in 24 quarters since. The position peaked at $4.44M in Q4 2021. 2,938 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

  • Souders Financial Advisors held 10,269 shares of Pfizer worth $288K as of Q1 2026.
  • Souders Financial Advisors bought 151 Pfizer shares in Q1 2026, an estimated $4.02K.
  • Pfizer made up 0.03% of Souders Financial Advisors's portfolio in Q1 2026, its #188 holding.
  • Souders Financial Advisors first reported a position in Pfizer in Q1 2020 and has held it in 24 quarters since.
  • Souders Financial Advisors's Pfizer position peaked at $4.44M in Q4 2021.
  • 2,938 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on Souders Financial Advisors's 13F filing for Q1 2026, filed 4 May 2026.